Cell & Gene Therapies

(Image: Getty/Tuomas Lehitnen)

SGS’ Glasgow biosafety facility doubles in size

By Maggie Lynch

SGS’ completed the ₤8.7m expansion of its large molecule testing facility in Glasgow and made room to increase its existing biosafety service and PCR platform capabilities.

(Image: Getty/Hakinmhan)

Roche suffers third delay on Spark deal

By Ben Hargreaves

Roche’s acquisition of Spark was announced at the start of the year but closing the deal has proved difficult after a third delay incurred to give the FTC extra review time.

Follow us

Products

View more

Webinars